Rosalind Helfrich

1.3k total citations
13 papers, 885 citations indexed

About

Rosalind Helfrich is a scholar working on Molecular Biology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rosalind Helfrich has authored 13 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rosalind Helfrich's work include Receptor Mechanisms and Signaling (4 papers), HIV Research and Treatment (3 papers) and Signaling Pathways in Disease (3 papers). Rosalind Helfrich is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), HIV Research and Treatment (3 papers) and Signaling Pathways in Disease (3 papers). Rosalind Helfrich collaborates with scholars based in United States, United Kingdom and Denmark. Rosalind Helfrich's co-authors include Robert L. Simmer, Dale J. Kempf, Daniel W. Norbeck, Judith Rittenhouse, John W. Erickson, William E. Kohlbrenner, Mark F. Knigge, Deborah A. Paul, Norman E. Wideburg and David J. Neidhart and has published in prestigious journals such as Science, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Rosalind Helfrich

13 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosalind Helfrich United States 11 447 356 289 191 89 13 885
John O. Hui United States 19 602 1.3× 500 1.4× 483 1.7× 123 0.6× 95 1.1× 42 1.3k
Duncan Armour United Kingdom 10 520 1.2× 531 1.5× 708 2.4× 186 1.0× 78 0.9× 14 1.5k
Rocco D. Gogliotti United States 19 669 1.5× 277 0.8× 251 0.9× 181 0.9× 45 0.5× 31 1.1k
Jean Vizzavona France 12 466 1.0× 67 0.2× 134 0.5× 133 0.7× 33 0.4× 18 741
Bernard‐Pierre Roques France 12 353 0.8× 70 0.2× 133 0.5× 88 0.5× 24 0.3× 18 577
Michael D. Minnich United States 10 246 0.6× 189 0.5× 161 0.6× 93 0.5× 22 0.2× 15 481
Christian Watson United States 5 554 1.2× 85 0.2× 127 0.4× 42 0.2× 94 1.1× 6 779
Christopher Higgs United Kingdom 12 432 1.0× 80 0.2× 100 0.3× 67 0.4× 115 1.3× 18 687
K De Vreese Belgium 18 379 0.8× 570 1.6× 708 2.4× 116 0.6× 22 0.2× 22 1.6k
Ya Zhu China 9 655 1.5× 97 0.3× 164 0.6× 23 0.1× 83 0.9× 13 1.0k

Countries citing papers authored by Rosalind Helfrich

Since Specialization
Citations

This map shows the geographic impact of Rosalind Helfrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalind Helfrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalind Helfrich more than expected).

Fields of papers citing papers by Rosalind Helfrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalind Helfrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalind Helfrich. The network helps show where Rosalind Helfrich may publish in the future.

Co-authorship network of co-authors of Rosalind Helfrich

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalind Helfrich. A scholar is included among the top collaborators of Rosalind Helfrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalind Helfrich. Rosalind Helfrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chakroborty, Shreaya, Evan S. Hill, Daniel Christian, et al.. (2019). Reduced presynaptic vesicle stores mediate cellular and network plasticity defects in an early-stage mouse model of Alzheimer’s disease. Molecular Neurodegeneration. 14(1). 7–7. 58 indexed citations
2.
Scanio, Marc J. C., Lei Shi, William H. Bunnelle, et al.. (2011). Structure–Activity Studies of Diazabicyclo[3.3.0]octane-Substituted Pyrazines and Pyridines as Potent α4β2 Nicotinic Acetylcholine Receptor Ligands. Journal of Medicinal Chemistry. 54(21). 7678–7692. 6 indexed citations
3.
Li, Tao, William H. Bunnelle, Keith B. Ryther, et al.. (2010). Syntheses and structure–activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel α7 neuronal nicotinic receptor (NNR) ligands. Bioorganic & Medicinal Chemistry Letters. 20(12). 3636–3639. 10 indexed citations
4.
Moreland, Robert B., Masaki Nakane, Diana L. Donnelly‐Roberts, et al.. (2004). Comparative pharmacology of human dopamine D2-like receptor stable cell lines coupled to calcium flux through Gαqo5. Biochemical Pharmacology. 68(4). 761–772. 35 indexed citations
5.
Warrior, Usha, Evelyn McKeegan, Linda Traphagen, et al.. (2003). Identification and Characterization of Novel Antagonists of the CCR3 Receptor. SLAS DISCOVERY. 8(3). 324–331. 11 indexed citations
6.
Gopalakrishnan, Sujatha M., Robert B. Moreland, James L. Kofron, et al.. (2003). A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors. Analytical Biochemistry. 321(2). 192–201. 17 indexed citations
7.
Stoll, Vincent S., Wenying Qin, Kent D. Stewart, et al.. (2002). X-ray crystallographic structure of ABT-378 (Lopinavir) bound to HIV-1 protease. Bioorganic & Medicinal Chemistry. 10(8). 2803–2806. 75 indexed citations
8.
McNally, Teresa, Rosalind Helfrich, Marlon Cowart, et al.. (1997). Cloning and Expression of the Adenosine Kinase Gene from Rat and Human Tissues. Biochemical and Biophysical Research Communications. 231(3). 645–650. 49 indexed citations
9.
Neri, Placido, Robert Meadows, Gerd Gemmecker, et al.. (1991). 1H,13C and 15N backbone assignments of cyclophilin when bound to cyclosporin A (CsA) and preliminary structural characterization of the CsA binding site. FEBS Letters. 294(1-2). 81–88. 24 indexed citations
10.
Holzman, Thomas F., David A. Egan, Rohinton Edalji, et al.. (1991). Preliminary characterization of a cloned neutral isoelectric form of the human peptidyl prolyl isomerase cyclophilin. Journal of Biological Chemistry. 266(4). 2474–2479. 35 indexed citations
11.
Rittenhouse, Judith, Rosalind Helfrich, Debra Weigl, et al.. (1990). Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose. Biochemical and Biophysical Research Communications. 171(1). 60–66. 27 indexed citations
12.
Erickson, John W., David J. Neidhart, Dale J. Kempf, et al.. (1990). Design, Activity, and 2.8 Å Crystal Structure of a C 2 Symmetric Inhibitor Complexed to HIV-1 Protease. Science. 249(4968). 527–533. 446 indexed citations
13.
Fesik, Stephen W., Robert T. Gampe, Thomas F. Holzman, et al.. (1990). Isotope-Edited NMR of Cyclosporin a Bound to Cyclophilin: Evidence for a Trans 9,10 Amide Bond. Science. 250(4986). 1406–1409. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026